Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00074204

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Broccoli Sprout Extract in Preventing Lung Cancer in Smokers

NCT00255775

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

NCT00673569

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00276588

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

Conditions: Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
Locations: Arizona Cancer Center Tuscon, Arizona, United States

Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States

H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States

Nevada Cancer Institute Sparks, Nevada, United States

View Trial Details

Completed

Radiotherapy for NSCLC to a Individualized MLD

NCT00573040

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: MAASTRO clinic, Maastricht Radiation Oncology Maastricht, Limburg, Netherlands

View Trial Details

Completed

Concurrent Chemo-radiation Form NSCLC to a Individualized MLD

NCT00572325

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: MAASTRO clinic, Maastricht Radiation Oncology Maastricht, Netherlands

View Trial Details

Completed

Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer

NCT00453167

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +8 more
Locations: National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea

View Trial Details

Completed

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

NCT00316225

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hanover, Germany

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain

View Trial Details

Completed

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00004225

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville, Tennessee, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions